Based primarily on animal studies with supporting human imaging data, GLP-1 receptor activation in the ventral tegmental area and nucleus accumbens appears to modulate dopamine signaling in response to palatable foods, potentially decreasing the rewarding properties of high-calorie foods
The conversation around these medications has evolved rapidly, from being prescribed solely for type 2 diabetes, to expanded use for the treatment of obesity, cardiovascular, kidney, and liver disease, as well as arthritis, sleep apnea and even for the treatment of substance abuse disorder
Favorable histological parameters associated with bone remodeling were also observed following ozone application in rats during orthodontic procedures, as well as in presence of diabetes, where increased numbers of bone morphogenetic protein 2-positive cells were reported (Faccini et al
This combination uses two distinct pathways to amplify GH release synergistically
(PMC) Creatine is not a weight loss drug